跳至主要内容
临床试验/NCT01390597
NCT01390597已完成不适用

The Molecular Mechanisms of Transformation in Peripheral T-cell and NK Lymphomas

Eastern Cooperative Oncology Group0 个研究点目标入组 32 人开始时间: 2011年6月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
32
主要终点
New somatically mutated genes in T-cell and NK lymphoma samples

研究概览

简要总结

RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors find better ways to treat the cancer.

PURPOSE: This research trial studies biomarkers in tumor tissue samples from patients with peripheral T-cell lymphoma or natural killer cell neoplasms.

详细描述

OBJECTIVES:

  • To identify mutations in oncogenes and tumor suppressors of peripheral T-cell lymphoma or natural killer (NK) cell neoplasm.
  • To delineate the mechanisms that mediate oncogenic effects and their clinical prognostic significance in these diseases.
  • To perform a comprehensive mutation analysis via whole exome resequencing in a panel of peripheral T-cell or NK lymphomas.

OUTLINE: Fixed paraffin-embedded tumor tissue samples are analyzed for mutations by the Illumina HiSeq platform. Sequencing reads are performed by GAPipeline version 1.5.1 and mapping on the human genome performed using the MAQ software version 0.7.1. Genes harboring validated somatic mutations are then amplified by PCR and analyzed by Sanger resequencing.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 120 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

New somatically mutated genes in T-cell and NK lymphoma samples

时间窗: 1 year

次要结局

未报告次要终点

研究者

申办方类型
Network
责任方
Sponsor

相似试验